US Patent 10716818 Oncolytic virotherapy and immunotherapy
Patent 10716818 was granted and assigned to Baylor College of Medicine on July, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
107168180
Date of Patent
July 21, 2020
0Patent Application Number
164303470
Date Filed
June 3, 2019
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 4 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 28 Dec, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
107168180
Date of Patent
July 21, 2020
0Patent Application Number
164303470
Date Filed
June 3, 2019
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10716818 Oncolytic virotherapy and immunotherapy
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10716818
Date of patent
July 21, 2020
Patent application number
16430347
Date Filed
June 3, 2019
Patent primary examiner
Find more entities like US Patent 10716818 Oncolytic virotherapy and immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
